These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37542344)
1. Analysis of the relationship between GLUT family in the progression and immune infiltration of head and neck squamous carcinoma. Li B Diagn Pathol; 2023 Aug; 18(1):88. PubMed ID: 37542344 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of the Role of Chu M; Zheng K; Li X; Luo Z; Yang X; Wei C Anal Cell Pathol (Amst); 2022; 2022():2371057. PubMed ID: 36247875 [TBL] [Abstract][Full Text] [Related]
3. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis. Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433 [TBL] [Abstract][Full Text] [Related]
4. CTHRC1 is a prognostic biomarker correlated with immune infiltration in head and neck squamous cell carcinoma. Zhang Z; Ren X; Wang Y; Liu P; Lin P; Jin S; Xu C BMC Oral Health; 2024 Jun; 24(1):742. PubMed ID: 38937712 [TBL] [Abstract][Full Text] [Related]
5. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
6. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Yang L; Lu P; Yang X; Li K; Chen X; Qu S Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376 [TBL] [Abstract][Full Text] [Related]
7. TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma. Yang Z; Li X; Li J; Su Q; Qiu Y; Zhang Z; Zhang L; Mo W Biomed Res Int; 2020; 2020():3962146. PubMed ID: 33083464 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive review regarding the association of E2Fs with the prognosis and immune infiltrates in human head and neck squamous cell carcinoma. Du W; Xia X; Gou Q; Xie Y; Gao L Asian J Surg; 2024 May; 47(5):2106-2121. PubMed ID: 38320907 [TBL] [Abstract][Full Text] [Related]
9. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
10. The Clinical Significance of Dickkopf Wnt Signaling Pathway Inhibitor Gene Family in Head and Neck Squamous Cell Carcinoma. Hu Y; Liu M; Xu S; Li S; Yang M; Su T; Yuan Z; Peng H Med Sci Monit; 2020 Nov; 26():e927368. PubMed ID: 33281184 [TBL] [Abstract][Full Text] [Related]
11. Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma. Zhou H; Cao T; Li WP; Wu G Mol Biol Rep; 2019 Jun; 46(3):2693-2701. PubMed ID: 30805892 [TBL] [Abstract][Full Text] [Related]
12. SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma. Lu T; Chen Y; Gong X; Guo Q; Lin C; Luo Q; Tu Z; Pan J; Li J Cancer Med; 2021 Nov; 10(21):7847-7862. PubMed ID: 34590792 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of CAV1 and CAV2 in Head and Neck Squamous Cell Carcinoma. He J; Ouyang S; Zhao Y; Liu Y; Liu Y; Zhou B; Man Q; Liu B; Wu T Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830672 [TBL] [Abstract][Full Text] [Related]
14. Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584 [TBL] [Abstract][Full Text] [Related]
15. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment. Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682 [TBL] [Abstract][Full Text] [Related]
16. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods. Jin Y; Yang Y Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688 [TBL] [Abstract][Full Text] [Related]
17. SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma. Shi Y; Liang Y; Wang W; Zhang G Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):2039-2048. PubMed ID: 34173014 [TBL] [Abstract][Full Text] [Related]
18. IKZF3 is a novel prognostic biomarker for head and neck squamous cell carcinoma: A study based on bioinformatics analysis. Li H; Ye M; Hu Z; Lu H; Zheng D; Wu M; Ge T; Xu S; Ge Z; Zhang S; Xu G; Chen H Medicine (Baltimore); 2023 Mar; 102(11):e33124. PubMed ID: 36930079 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis. Li YY; Jin F; Zhou JJ; Yu F; Duan XF; He XY; Wang R; Wu WL; Long JH; Luo XL Chronobiol Int; 2019 Dec; 36(12):1723-1732. PubMed ID: 31609143 [TBL] [Abstract][Full Text] [Related]
20. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma. Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]